1 completed, 1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow pazufloxacin: new trials by email Literature Review of pazufloxacin trials Research Report on pazufloxacin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. Pazufloxacin, Zymar - Conjunctivitis, Bacterial | Phase 3 | Terminated | Laboratorios Sophia S.A de C.V. | 46 | 2018-10-01 | 2021-08-24 |
| Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin) PRO-157, Vigamox, Zymar® - Bacterial Conjunctivitis | Phase 2 | Completed | Laboratorios Sophia S.A de C.V. | 150 | 2015-03-01 | 2019-05-22 |
Laboratorios Sophia S.A de C.V. (2)
Mexico (2)